Greenyn Biotechnology Co., Ltd (6846.TWO)
TWD 77.8
(0.0%)
TWD 77.8
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 127.1 Million | 229.73 Million | 81.79 Million | 254.1 Million | - |
| Net Income | 165.83 Million | 184 Million | 169.02 Million | 157.12 Million | - |
| Depreciation & Amortization | 24.91 Million | 25.14 Million | 23.28 Million | 28.66 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 5.08 Million | 1.7 Million | 4.73 Million | 6.42 Million | - |
| Change in working capital | -29.93 Million | 53.43 Million | -90.7 Million | 67.18 Million | - |
| Other non-cash items | -3.66 Million | 36 Thousand | 1.07 Million | 1.47 Million | - |
| Investing Cash Flow | -155.75 Million | -16.41 Million | -18.82 Million | -3.81 Million | - |
| Investments in PPE | -89.37 Million | -17.14 Million | -17.74 Million | -4.33 Million | - |
| Acquisitions | - | - | - | - | 3.89 Million |
| Investment purchases | -62.7 Million | - | -80 Million | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -3.67 Million | -1.21 Million | -3.66 Million | 487 Thousand | - |
| Financing Cash Flow | 191.85 Million | -199.15 Million | -90.97 Million | -30.85 Million | - |
| Debt repayment | -100 Million | -10 Million | -40 Million | -20.83 Million | - |
| Dividends payments | -95.21 Million | -200.18 Million | -48.3 Million | -30 Million | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 197.36 Million | - | 6.24 Million | 30 Million | - |
| Other Financing Activities | -904 Thousand | - | - | 30 Million | - |
| Accounts receivables | -9.45 Million | - | - | - | - |
| Accounts payables | 11.61 Million | - | - | - | - |
| Inventory | -2.1 Million | -45.12 Million | 14.88 Million | 923 Thousand | - |
| Other working capital | -18.37 Million | - | - | - | - |
| Cash at beginning of period | 370.29 Million | 356.13 Million | 384.13 Million | 164.7 Million | - |
| Cash at end of period | 533.5 Million | 370.29 Million | 356.13 Million | 384.13 Million | - |
| Capital Expenditure | -89.37 Million | -17.14 Million | -17.74 Million | -4.33 Million | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 163.2 Million | 14.16 Million | -28 Million | 219.43 Million | - |
| Free Cash Flow | 37.73 Million | 212.58 Million | 64.05 Million | 249.76 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 31.04 Million | 53.19 Million | 47.41 Million | 165.83 Million | 37.9 Million | 40.5 Million |
| Depreciation & Amortization | 6.7 Million | 7.39 Million | 6.73 Million | 24.91 Million | 6.18 Million | 6.05 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 185 Thousand | 171 Thousand | 191 Thousand | 5.08 Million | 345 Thousand | 4.35 Million |
| Change in working capital | 50.51 Million | -29.38 Million | -14.24 Million | -29.93 Million | -3.65 Million | -1.41 Million |
| Other non-cash items | -2.48 Million | -880 Thousand | -1.76 Million | -3.66 Million | 45 Thousand | -1.43 Million |
| Investing Cash Flow | 117.61 Million | -59.62 Million | -150.33 Million | -155.75 Million | -323 Thousand | 23.32 Million |
| Investments in PPE | -3.37 Million | -1.92 Million | -81.91 Million | -89.37 Million | -373 Thousand | -2.48 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | 57.49 Million | -57.49 Million | -62.7 Million | -62.7 Million | - | - |
| Sales/Maturities of investments | 63.5 Million | - | - | - | - | - |
| Other Investing Activities | -16 Thousand | -210 Thousand | -5.71 Million | -3.67 Million | 50 Thousand | 25.81 Million |
| Financing Cash Flow | -245.6 Million | 17.89 Million | 89.41 Million | 191.85 Million | -12.29 Million | 97.23 Million |
| Debt repayment | -150 Million | -20 Million | -90 Million | -100 Million | -10 Million | - |
| Dividends payments | -93.91 Million | - | - | -95.21 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 413 Thousand | 1.45 Million | 197.36 Million | 137 Thousand | 195.77 Million |
| Other Financing Activities | -1.69 Million | - | - | -904 Thousand | - | - |
| Accounts receivables | 39.94 Million | - | - | - | - | - |
| Accounts payables | 8.72 Million | - | - | - | - | - |
| Inventory | -5.82 Million | 10.1 Million | -3.11 Million | -2.1 Million | -9.79 Million | -2.49 Million |
| Other working capital | 8.36 Million | - | - | - | - | - |
| Cash at beginning of period | 523.56 Million | 533.5 Million | 554.67 Million | 370.29 Million | 543.81 Million | 395.99 Million |
| Cash at end of period | 462.44 Million | 523.56 Million | 533.5 Million | 533.5 Million | 554.67 Million | 543.81 Million |
| Capital Expenditure | -3.37 Million | -1.92 Million | -81.91 Million | -89.37 Million | -373 Thousand | -2.48 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -61.11 Million | -9.94 Million | -21.17 Million | 163.2 Million | 10.86 Million | 147.81 Million |
| Free Cash Flow | 63.5 Million | 29.86 Million | -42.16 Million | 37.73 Million | 23.11 Million | 24.76 Million |
KODK
005680
BPIRF
6973
IVT
256150